Viewing Study NCT02935205


Ignite Creation Date: 2025-12-25 @ 3:11 AM
Ignite Modification Date: 2026-02-28 @ 10:35 PM
Study NCT ID: NCT02935205
Status: UNKNOWN
Last Update Posted: 2023-11-29
First Post: 2016-10-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Enzalutamide and Indomethacin in Treating Patients With Recurrent or Metastatic Hormone-Resistant Prostate Cancer
Sponsor: Mamta Parikh
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Prostate Carcinoma View
None Recurrent Prostate Carcinoma View
None Stage IV Prostate Cancer View
Keywords: